Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients

被引：27
|
作者：
Rocio, Carolina [1 ]
Amato, Valdir Sabbaga [1 ]
Camargo, Raphael A. [1 ]
Tuon, Felipe F. [2 ]
Nicodemo, Antonio Carlos [1 ]
机构：
[1] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil
[2] Univ Fed Parana, Clin Univ Hosp, Div Infect Dis, BR-80060000 Curitiba, PR, Brazil
来源：
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2014年 / 108卷 / 03期
关键词：
Amphotericin B; Leishmania treatment; Leishmaniasis;
D O I：
10.1093/trstmh/tru011
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Background: Studies assessing the efficacy of liposomal amphotericin B (LAB) in the treatment of patients with mucosal leishmaniasis (ML) are very scarce in the literature and an optimal dose regimen has not yet been defined. Methods: We performed a retrospective and descriptive analysis from records of 16 patients with ML treated with LAB. The mean daily dose of LAB was 2.5 mg/kg/day. Results: Healing of the lesion was observed in 14 (88%) of the 16 patients. The mean cumulative doses, excluding the two treatment failures, were 2265 mg and 33 mg/kg. Conclusion: Liposomal amphotericin B in the cumulative dose of 30 to 35 mg/kg was able to achieve 100% effectiveness.
引用
收藏
页码：176 / 178
页数：3
相关论文
共 50 条
  • [1] Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B
    Amato, Valdir Sabbaga
    Tuon, Felipe Francisco
    Campos, Aleia
    Bacha, Helio Arthur
    Nicodemo, Antonio Carlos
    Neto, Vicente Amato
    Shikanai-Yasuda, Maria Aparecida
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) : 311 - 312
  • [2] Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
    Jaafari, Mahmoud Reza
    Hatamipour, Mahdi
    Alavizadeh, Seyedeh Hoda
    Abbasi, Azam
    Saberi, Zahra
    Rafati, Sima
    Taslimi, Yasaman
    Mohammadi, Akram Miramin
    Khamesipour, Ali
    [J]. INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2019, 11 : 156 - 165
  • [3] Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients
    Minodier, P
    Retornaz, K
    Horelt, A
    Garnier, JM
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2003, 17 (02) : 183 - 188
  • [4] Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients
    Vigna, E.
    De Vivo, A.
    Gentile, M.
    Morelli, R.
    Lucia, E.
    Mazzone, C.
    Recchia, A. G.
    Vianelli, N.
    Morabito, F.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (05) : 428 - 431
  • [5] Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B
    Machado, Paulo R. L.
    Rosa, Maria Elisa A.
    Guimaraes, Luis H.
    Prates, Fernanda V. O.
    Queiroz, Adriano
    Schriefer, Albert
    Carvalho, Edgar M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 (06) : 945 - 949
  • [6] Liposomal amphotericin B as a treatment for human leishmaniasis
    Balasegaram, Manica
    Ritmeijer, Koert
    Lima, Maria Angeles
    Burza, Sakib
    Genovese, Gemma Ortiz
    Milani, Barbara
    Gaspani, Sara
    Potet, Julien
    Chappuis, Francois
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2012, 17 (04) : 493 - 510
  • [7] Treatment of cutaneous leishmaniasis with liposomal amphotericin B
    del Rosal Rabes, T.
    Baquero-Artigao, F.
    Gomez Fernandez, C.
    Garcia Miguel, M. J.
    de Lucas Laguna, R.
    [J]. ANALES DE PEDIATRIA, 2010, 73 (02): : 101 - 102
  • [8] Treatment of visceral leishmaniasis with liposomal amphotericin B
    不详
    [J]. HOSPITAL MEDICINE, 2001, 62 (09): : 577 - 577
  • [9] Liposomal amphotericin B for the treatment of visceral leishmaniasis
    Bern, Caryn
    Adler-Moore, Jill
    Berenguer, Juan
    Boelaert, Marleen
    den Boer, Margriet
    Davidson, Robert N.
    Figueras, Concepcion
    Gradoni, Luigi
    Kafetzis, Dimitris A.
    Ritmeijer, Koert
    Rosenthal, Eric
    Royce, Catherine
    Russo, Rosario
    Sundar, Shyam
    Alvar, Jorge
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) : 917 - 924
  • [10] Visceral leishmaniasis in HIV infected patients: Treatment with high dose liposomal amphotericin B (AmBisome)
    Russo, R
    Nigro, LC
    Minniti, S
    Montineri, A
    Gradoni, L
    Caldeira, L
    Davidson, RN
    [J]. JOURNAL OF INFECTION, 1996, 32 (02) : 133 - 137
12345